Financhill
Back

Arbutus Biopharma Vs. GlycoMimetics Industry Stock Comparison

Sell
27

ABUS
Arbutus Biopharma

Last Price:
$3.20
Seasonality Move:
21.65%
Sell
18

GLYC
GlycoMimetics

Last Price:
$0.23
Seasonality Move:
-6.72%
Sell
27
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.21. The Score for ABUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy, Sell or Hold?

  • The current GlycoMimetics [GLYC] share price is $0.23. The Score for GLYC is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • GLYC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.

GLYC Stock Price Chart

What is GlycoMimetics's stock price today?

  • The GlycoMimetics share price today is $0.23
    The current trend is relatively stagnant and GLYC is experiencing slight buying pressure.

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 33.79 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.35 - 3.65) Sell
Bollinger Bands (100): (3.53 - 4.11) Sell

GLYC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 39.32 Sell
Chaikin Money Flow: 430722 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.25 - 0.35) Sell
Bollinger Bands (100): (0.14 - 0.32) Buy

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.41 Sell
20-day SMA: 3.5 Sell
50-day SMA: 3.71 Sell
200-day SMA: 3.44 Sell
8-day EMA: 3.37 Sell
20-day EMA: 3.49 Sell
50-day EMA: 3.63 Sell
200-day EMA: 3.44 Sell

GLYC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.24 Sell
20-day SMA: 0.28 Sell
50-day SMA: 0.3 Sell
200-day SMA: 0.7 Sell
8-day EMA: 0.24 Sell
20-day EMA: 0.27 Sell
50-day EMA: 0.28 Sell
200-day EMA: 0.66 Sell

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

GlycoMimetics Earnings Growth & GLYC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

GlycoMimetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):